Literature DB >> 31531516

Interchangeability and substitution of biosimilars: is health technology assessment (HTA) a tool for decision-making?

Bruna de Oliveira Ascef1,2, Renan Gonçalves Leonel da Silva1, Haliton Alves de Oliveira Júnior2, Patrícia Coelho De Soárez1.   

Abstract

Mesh：

Substances：

Year:  2019        PMID： 31531516     DOI： 10.1590/0102-311X00087219

Source DB:  PubMed          Journal:  Cad Saude Publica        ISSN： 0102-311X            Impact factor:   1.632


× No keyword cloud information.
  2 in total

1.  A Cross-Sectional Study of Quality of Life Among Brazilian Adults With Type 1 Diabetes Treated With Insulin Glargine: Findings and Implications.

Authors:  Paulo H R F Almeida; Brian Godman; Vania Dos Santos Nunes-Nogueira; Lívia L P de Lemos; Francisco de Assis Acúrcio; Augusto A Guerra-Junior; Vânia E de Araújo; Alessandra M Almeida; Juliana Alvares-Teodoro
Journal:  Clin Diabetes       Date:  2022

Review 2.  Health technology assessment of biosimilars worldwide: a scoping review.

Authors:  Bruna de Oliveira Ascef; Ana Carolina de Freitas Lopes; Patrícia Coelho de Soárez
Journal:  Health Res Policy Syst       Date:  2020-08-26
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.